Feasibility study of cavitation-induced liposomal doxorubicin release in an AT2 Dunning rat tumor model

Author： Lafon Cyril Somaglino Lucie Bouchoux Guillaume Mari Jean Martial Chesnais Sabrina Ngo Jacqueline Mestas Jean-Louis Fossheim Sigrid L. Nilssen Esben A. Chapelon Jean-Yves

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.20, Iss.8, 2012-09, pp. : 691-702

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiretrovirals/dexamethasone/doxorubicin liposomal: Osteoporosis (first report with doxorubicin liposomal and emtricitabine)?: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1205, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Bioavailability and therapeutic efficacy of HER2 scFv-targeted liposomal doxorubicin in a murine model of HER2-overexpressing breast cancer

By Laginha Kimberley Moase Elaine Yu Ning Huang Anthony Allen T. M.

Journal of Drug Targeting, Vol. 16, Iss. 7-8, 2008-08 ,pp. : 605-610

Informa Healthcare

Access to resources Recommend Favorite

Phase I study of liposomal doxorubicin (Doxil) and cyclophosphamide in solid tumors

By El-Rayes Basil F. Ibrahim Dina Shields Anthony F. LoRusso Patricia M. Zalupski Mark M. Philip Philip A.

Investigational New Drugs, Vol. 23, Iss. 1, 2005-01 ,pp. : 57-62

Springer Publishing Company

Access to resources Recommend Favorite

Doxorubicin liposomal/paclitaxel: Dermatological disorders: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1199, 2008-01 ,pp. : 20-21

Adis International

Access to resources Recommend Favorite

Doxorubicin liposomal: Intertriginous eruption and palmoplantar erythrodysaesthesia: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1255, 2009-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite